文献速递生殖医学

POSEIDON 3/4组中AMH与可用胚胎数的相关性

The correlation between AMH and number of embryos in POSEIDON groups: a retrospective cohort study.
PubMed 文献 · Reprod Biomed Online · 2020-12-26

该回顾性队列研究纳入412个POSEIDON 3/4组(AFC≤5且AMH<1.2 ng/ml)的IVF/ICSI刺激周期,分析血清AMH浓度与每周期可用胚胎数的关联。调整年龄、基线FSH、刺激方案和AFC后,AMH每增加0.1 ng/ml,可用胚胎数增加0.1(95%CI 0.06-0.14)。高AMH组(0.52-1.19 ng/ml)可用胚胎数较低AMH组(0.06-0.24 ng/ml)多0.62(95%CI 0.37-0.97)。

要点

  • POSEIDON 3/4组中AMH越高,IVF/ICSI可用胚胎数越多。
  • 调整协变量后AMH每增0.1 ng/ml,胚胎数增0.1(95%CI 0.06-0.14)。
  • 高AMH组(0.52-1.19 ng/ml)比低AMH组胚胎数多0.62(95%CI 0.37-0.97)。

核心结论

  • POSEIDON 3/4组患者中较高的AMH与IVF/ICSI可用胚胎数增加相关。
  • AMH可用于评估潜在生殖预后,以减少因低估而放弃治疗或进行多次无效刺激周期。

研究设计与样本

  • 回顾性队列研究,纳入2017年1月至2019年3月新疆医科大学第一附属医院生殖中心412个IVF/ICSI完整治疗周期。
  • 研究对象为POSEIDON 3/4组患者(AFC≤5且AMH<1.2 ng/ml)。
  • 卵巢刺激方案为PPOS或GnRH拮抗剂方案。

主要发现

  • 调整年龄、基线FSH、刺激方案和AFC后,AMH每增加0.1 ng/ml,可用胚胎数增加0.1(95%CI 0.06-0.14)。
  • 将AMH三分位分类后敏感性分析显示,高AMH组(0.52-1.19 ng/ml)可用胚胎数较低AMH组(0.06-0.24 ng/ml)多0.62(95%CI 0.37-0.97)。

临床怎么用

  • 对POSEIDON 3/4组患者,可参考AMH水平评估IVF/ICSI可用胚胎数的潜在预后。
  • 避免因低估预后而放弃治疗,或实施多次无效的刺激周期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the association between serum anti-Müllerian hormone (AMH) concentrations and the number of utilizable embryos obtained per stimulation cycle of IVF/intracytoplasmic sperm injection (ICSI) in POSEIDON Groups 3 and 4? DESIGN: Retrospective cohort study of 412 cycles, in which patients in POSEIDON Groups 3 and 4 (antral follicle count [AFC] ≤5 and AMH <1.2 ng/ml) underwent complete IVF/ICSI treatment cycles in the Reproductive Center of the First Affiliated Hospital of Xinjiang Medical University between January 2017 and March 2019. Patients underwent IVF/ICSI treatment using either progestin-primed ovarian stimulation (PPOS) or gonadotrophin-releasing hormone (GnRH) antagonist protocol as ovarian stimulation protocol. RESULTS: Three models were established to analyse the correlation between AMH and the number of utilizable embryos in this study. After adjusting for covariates (age, baseline FSH, stimulation protocol and AFC), the number of embryos increased by 0.1 (95% confidence interval [CI] 0.06-0.14) with each increment of 0.1 ng/ml in AMH concentration. AMH was transformed from a continuous variable to a categorical variable (through trisection of AMH concentrations) and for the sensitivity analysis it was found that the number of embryos in the high AMH group (0.52-1.19 ng/ml) was 0.62 (95% CI 0.37-0.97) higher than in the low AMH group (0.06-0.24 ng/ml). CONCLUSIONS: High AMH in patients in POSEIDON Groups 3 and 4 was found to be associated with an increase in the number of available embryos in IVF/ICSI. The potential reproductive prognosis can be assessed by AMH, to reduce the abandonment of treatment due to underestimation or to implement multiple ineffective stimulation cycles of treatment.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Tian H, Mao X, Su N, et al. The correlation between AMH and number of embryos in POSEIDON groups: a retrospective cohort study. Reprod Biomed Online. 2020. PMID: 33736991. doi:10.1016/j.rbmo.2020.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。